| Programmable polyproteams built using twin peptide superglues G Veggiani, T Nakamura, MD Brenner, RV Gayet, J Yan, CV Robinson, ... Proceedings of the National Academy of Sciences 113 (5), 1202-1207, 2016 | 324 | 2016 |
| SpyLigase peptide–peptide ligation polymerizes affibodies to enhance magnetic cancer cell capture JO Fierer, G Veggiani, M Howarth Proceedings of the National Academy of Sciences 111 (13), E1176-E1181, 2014 | 202 | 2014 |
| Superglue from bacteria: unbreakable bridges for protein nanotechnology G Veggiani, B Zakeri, M Howarth Trends in biotechnology 32 (10), 506-512, 2014 | 143 | 2014 |
| Mutations and evolution of the SARS-CoV-2 spike protein N Magazine, T Zhang, Y Wu, MC McGee, G Veggiani, W Huang Viruses 14 (3), 640, 2022 | 142 | 2022 |
| Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidase G Veggiani, A de Marco Protein expression and purification 79 (1), 111-114, 2011 | 83 | 2011 |
| Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies S Djender, A Schneider, A Beugnet, R Crepin, KE Desrumeaux, ... Microbial cell factories 13, 1-10, 2014 | 80 | 2014 |
| SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly M Fairhead, G Veggiani, M Lever, J Yan, D Mesner, CV Robinson, ... Journal of the American Chemical Society 136 (35), 12355-12363, 2014 | 76 | 2014 |
| Emerging drug development technologies targeting ubiquitination for cancer therapeutics G Veggiani, MCR Gerpe, SS Sidhu, W Zhang Pharmacology & therapeutics 199, 139-154, 2019 | 60 | 2019 |
| Whole-cell biopanning with a synthetic phage display library of nanobodies enabled the recovery of follicle-stimulating hormone receptor inhibitors R Crepin, G Veggiani, S Djender, A Beugnet, F Planeix, C Pichon, ... Biochemical and biophysical research communications 493 (4), 1567-1572, 2017 | 25 | 2017 |
| Structural and functional characterization of a ubiquitin variant engineered for tight and specific binding to an alpha‐helical ubiquitin interacting motif N Manczyk, BP Yates, G Veggiani, A Ernst, F Sicheri, SS Sidhu Protein Science 26 (5), 1060-1069, 2017 | 25 | 2017 |
| Single-domain antibodies that compete with the natural ligand fibroblast growth factor block the internalization of the fibroblast growth factor receptor 1 G Veggiani, G Ossolengo, M Aliprandi, U Cavallaro, A de Marco Biochemical and Biophysical Research Communications 408 (4), 692-696, 2011 | 23 | 2011 |
| Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cells J Jain, G Veggiani, M Howarth Cancer research 73 (7), 2310-2321, 2013 | 22 | 2013 |
| Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis G Veggiani, H Huang, BP Yates, J Tong, T Kaneko, R Joshi, SSC Li, ... Protein Science 28 (2), 403-413, 2019 | 16 | 2019 |
| Comparative analysis of fusion tags used to functionalize recombinant antibodies G Veggiani, B Giabbai, MS Semrau, B Medagli, V Riccio, G Bajc, P Storici, ... Protein Expression and Purification 166, 105505, 2020 | 13 | 2020 |
| The ubiquitin interacting motifs of USP37 act on the proximal Ub of a di-Ub chain to enhance catalytic efficiency N Manczyk, G Veggiani, J Teyra, AW Strilchuk, SS Sidhu, F Sicheri Scientific Reports 9 (1), 4119, 2019 | 12 | 2019 |
| Transmembrane protein rotaxanes reveal kinetic traps in the refolding of translocated substrates J Feng, P Martin-Baniandres, MJ Booth, G Veggiani, M Howarth, H Bayley, ... Communications Biology 3 (1), 159, 2020 | 11 | 2020 |
| Dimerization of a ubiquitin variant leads to high affinity interactions with a ubiquitin interacting motif N Manczyk, G Veggiani, GD Gish, BP Yates, A Ernst, SS Sidhu, F Sicheri Protein Science 28 (5), 848-856, 2019 | 9 | 2019 |
| Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis J Zuin, G Veggiani, P Pengo, A Gallotta, A Biasiolo, N Tono, A Gatta, ... Clinical chemistry and laboratory medicine 48 (2), 217-223, 2010 | 9 | 2010 |
| High-affinity chromodomains engineered for improved detection of histone methylation and enhanced CRISPR-based gene repression G Veggiani, R Villaseñor, GD Martyn, JQ Tang, MW Krone, J Gu, C Chen, ... Nature Communications 13 (1), 6975, 2022 | 8 | 2022 |
| Engineered SH2 domains for targeted phosphoproteomics GD Martyn, G Veggiani, U Kusebauch, SR Morrone, BP Yates, AU Singer, ... ACS chemical biology 17 (6), 1472-1484, 2022 | 8 | 2022 |
